D289badc E0dd 4c89 A32f Bc06574a34d0 01
Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 68254-5002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 68254-5002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Concord Biotech Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
D289badc E0dd 4c89 A32f Bc06574a34d0 02
Each film-coated tablet contains mycophenolate sodium, USP equivalent to mycophenolic acid 180 mg. The tablets must be stored at 25°C (77°F); excursions permitted from 15° to 30°C (59° to 86°F). The package must be protected from moisture and dispensed in tight containers, USP. The manufacturer is Concord Biotech Limited, located in Valthera, Ahmedabad - 382225, Gujarat, India. The medication guide should be dispensed to each patient. This drug is only available through prescription, and the usual dosage should be verified from the package insert.*
D289badc E0dd 4c89 A32f Bc06574a34d0 03
This is a description of a package of film-coated tablets containing mycophenolate sodium manufactured by Concord Biotech Limited. The tablets are child-resistant and contain 360 mg of mycophenolic acid. The package contains 120 tablets and should be stored at a controlled room temperature to protect from moisture. The medication guide should be dispensed to each patient and the drug should be kept out of reach of children. The usual dosage should be determined by consulting the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
